Furthermore, strong Endocan expression in high-grade serous carcinoma of the ovary, which has the worst prognosis among EOCs, could be supportive of this association and another proof for the hypothesis that Endocan can be a predictor for tumor prognosis. The gene discussed is ESM1; the disease is ovarian serous adenocarcinoma.